Playlist


Inaugural Session of the Joint Turkmen-Slovak Intergovernmental Commission on Economic Cooperation Held
18 Jun. 05:25The Joint Turkmen-Slovak Intergovernmental Commission on Economic Cooperation convened its historic first session, bringing together committee chairs, policymakers, and senior officials from both nations. The high-level talks represent a pivotal milestone designed to elevate trade and economic interactions between Turkmenistan and the Slovak Republic to a premium level.
As reported by the "Watan" news program, the session offered Slovak partners a comprehensive overview of Turkmenistan's robust economic growth trajectories, operational capacities, and distinct strategic investment benefits. Concurrently, the Slovak delegation presented a detailed breakdown of their own national economic core strengths, identifying specific avenues for mutual commercial ventures.
To systematically expand trade ties, the commission agreed to prioritize establishing a structured framework to exchange data regarding upcoming commercial trade exhibitions, forums, and corporate events hosted within both countries. Concurrently, they will assess and facilitate bilateral business missions, B2B networking events, and site visits for private sector executives and entrepreneurs from both states. The commission also directed relevant ministries and sectoral departments to launch expert-level consultations in the near future to diversify import-export portfolios and optimize overall trade volumes. A series of targeted bilateral breakout meetings were also conducted on the sidelines of the commission's inaugural session to solidify sector-specific agreements.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.